Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Novel Non-Invasive Liver Fibrosis Tests Are Effective Biopsy Alternatives
February 2026
Novel non-invasive liver disease assessments (NILDAs) are effective liver biopsy alternatives for fibrosis, a 2026 systematic review has found.
Read more
25 Sep 2018
Hepatitis C Virus Treatment Just as Effective in the Elderly Population
Elderly patients infected with the hepatitis C virus (HCV) can be treated with direct-acting antivirals (DAA) safely and effectively, according to new…
9
Mins
4 Sep 2018
Alcohol or Not: A Review Comparing Initial Mechanisms, Contributing Factors, and Liver Transplantation Outcomes Between Alcoholic and Nonalcoholic Steatohepatitis
Chronic liver diseases take many forms; alcohol-related liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD) are two common illnesses that…
23 Aug 2018
Gut Enzymes Could Make Any Blood Type Universally Available
Blood could become far more accessible following the discovery of a group of enzymes that are able to turn any type of blood into type O, which can be…
14
Mins
27 Jul 2018
Primary Biliary Cholangitis in Motion Meeting
The purpose of the meeting was to work towards unified best practice in the treatment of primary biliary cholangitis (PBC). This centred on a theme of…
25 Jun 2018
New Scoring System to Improve HCV Treatment
A new scoring system can predict which patients with decompensated cirrhosis caused by hepatitis C virus (HCV) infection would benefit the most from…
25 Jun 2018
Statins Underutilised in NAFLD Patients
Statins are reported to be underutilised in nonalcoholic fatty liver disease (NAFLD) patients, according to a recent study by researchers at the New…
12
Mins
7 Jun 2018
Modern Methods for Studying Portal Hypertension-Associated Angiogenesis in Experimental Research
Portal hypertension (PH) is associated with the majority of severe complications occurring in liver cirrhosis, and an increase in hepatic vascular…
11
Mins
7 Jun 2018
Practical Diagnosis and Staging of Nonalcoholic Fatty Liver Disease: A Narrative Review
As the rates of obesity increase worldwide, the prevalence of nonalcoholic fatty liver disease (NAFLD) has risen and it is now the most common cause of…
Loading posts...
« Previous
1
…
54
55
56
57
58
…
76
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View